Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial.
Respir Res. 2022 Aug 9;23(1):202. doi: 10.1186/s12931-022-02126-2.
Respir Res. 2022.
PMID: 35945604
Free PMC article.
Clinical Trial.
Lung epithelial cells: Upstream targets in type 2-high asthma.
Lameire S, Hammad H.
Lameire S, et al.
Eur J Immunol. 2023 Nov;53(11):e2250106. doi: 10.1002/eji.202250106. Epub 2023 Feb 27.
Eur J Immunol. 2023.
PMID: 36781404
Review.
Item in Clipboard
A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19.
Van Damme KFA, Hoste L, Declercq J, De Leeuw E, Maes B, Martens L, Colman R, Browaeys R, Bosteels C, Verwaerde S, Vermeulen N, Lameire S, Debeuf N, Deckers J, Stordeur P, Depuydt P, Van Braeckel E, Vandekerckhove L, Guilliams M, Schetters STT, Haerynck F, Tavernier SJ, Lambrecht BN.
Van Damme KFA, et al. Among authors: lameire s.
Sci Transl Med. 2023 Aug 23;15(710):eadi0252. doi: 10.1126/scitranslmed.adi0252. Epub 2023 Aug 23.
Sci Transl Med. 2023.
PMID: 37611083
Item in Clipboard
Cite
Cite